From Genes to Membrane Failure: Genetic Determinants of Peritoneal Dialysis Physiology and Outcomes
Genes · 07.06.2026 · 17 (6) · 665
DOI: 10.3390/genes17060665 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 07.06.2026. Verfasst von Ola Suliman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Donal O'Donoghue Renal Research Centre, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Stott Lane, Salford M6 8HD, UK. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Kidney Failure, Chronic, Peritoneum. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Peritoneal dialysis (PD) has long been an established modality of renal replacement therapy for patients with end-stage kidney disease (ESKD). Despite the modality’s advantages, significant inter-individual variability exists in peritoneal membrane transport characteristics, ultrafiltration capacity, and long-term technique survival. While PD therapy-related factors, such as dialysis solution composition, peritonitis episodes, and duration of therapy, contribute to these outcomes, genetic factors also play important roles in peritoneal membrane biology. Genetic studies have identified polymorphisms in genes involved in angiogenesis, inflammation, fibrosis, and endothelial function that influence PD outcomes. Variants in genes such as vascular endothelial growth factor, interleukin-6, transforming growth factor-β1, angiotensin-converting enzyme, endothelial nitric oxide synthase, and aquaporin-1 have all been reported to be associated with differences in peritoneal transport and susceptibility to membrane failure. These genetic discoveries provide significant insights into the pathways that lead to alterations in the PD membrane structure and function. This review article aims to explore current evidence on key genetic determinants of peritoneal membrane transport, inflammatory responses, and fibrotic transformation in PD, and to discuss their potential implications for personalised dialysis therapy and future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Donal O'Donoghue Renal Research Centre, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Stott Lane, Salford M6 8HD, UK.
- Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
- Department of Renal Medicine, Royal North Shore Hospital, Northern Sydney Local Health District, St. Leonards, Sydney, NSW 2065, Australia.
- Faculty of Medicine & Health Sciences, Macquarie University, Macquarie Park, Sydney, NSW 2113, Australia.
- Department of Medicine, Northern Beaches Hospital, Northern Sydney Local Health District, Frenchs Forest, Sydney, NSW 2086, Australia.
ORCID-Profile: Henry H L Wu, Rajkumar Chinnadurai
Zitieren
APA
Suliman, O., Wu, H. H. L., Killen, J. P., Kalra, P. A., & Chinnadurai, R. (2026). From Genes to Membrane Failure: Genetic Determinants of Peritoneal Dialysis Physiology and Outcomes. Genes, 17(6), 665. https://doi.org/10.3390/genes17060665
Vancouver
Suliman O, Wu HHL, Killen JP, Kalra PA, Chinnadurai R. From Genes to Membrane Failure: Genetic Determinants of Peritoneal Dialysis Physiology and Outcomes. Genes. 2026;17(6):665. doi:10.3390/genes17060665
BibTeX
@article{Suliman2026,
author = {Suliman, Ola and Wu, Henry H L and Killen, John Paul and Kalra, Philip A and Chinnadurai, Rajkumar},
title = {From Genes to Membrane Failure: Genetic Determinants of Peritoneal Dialysis Physiology and Outcomes},
journal = {Genes},
year = {2026},
volume = {17},
number = {6},
pages = {665},
doi = {10.3390/genes17060665}
}
EUVIMED